Meet Andrew, CEO of RIVIOBIO
Education
Bachelors of Science in Molecular Biosciences and Biotechnology from Arizona State University
Masters of Science in Regulatory Sciences and Health Safety from Arizona State University
Masters of Business Administration with an emphasis on healthcare management from The Johns Hopkins University
As the CEO of RivioBio Andrew brings a unique blend of leadership, scientific expertise, and a deep commitment to advancing healthcare. With years of experience managing clinical phased studies, he has honed his skills in navigating the complexities of drug development and regulatory environments to bring innovative therapies to market.
At RivioBio, he sucessfully leads a dedicated team focused on pioneering biotechnological advancements that address unmet medical needs. His work is driven by a passion for innovation and a mission to improve patient outcomes through cutting-edge therapeutic solutions.
His career is built on a foundation of scientific inquiry, strategic vision, and a relentless pursuit of excellence. Andrew is dedicated to pushing the boundaries of what’s possible in biotechnology and clinical research, with the ultimate goal of transforming patient care on a global scale.
Personal Highlights:
Andrew enjoys the outdoors and spends many days a year hiking many of the beautiful trails Arizona has to offer. He enjoys traveling the world with his wife, and is an advid theme park enthusiest which he loves taking with his friends and family along for the ride. Andrew is also an avid lover of the arts, and is often listening to a wide range of music genres, attending theatre & musical performances, and plays several instruments in his spare time.
“Our therapeutic development should focus on patient needs, rather then simply relying on market data to determine our research pathways. Riviobio has an commitment to our communities to ensure we are providing therapies and services that better healthcare and ultimatly extend the lives of patients.”